An Extremely Rare Case of Disseminated Peritoneal Leiomyomatosis with a Pelvic Leiomyosarcoma and Omental Metastasis after Laparoscopic Morcellation: Systematic Review of the Literature
Authors:
- Antonella VimercatiAntonella Vimercati
- Carla Mariaflavia SantarsieroCSCarla Mariaflavia Santarsiero
- Angela EspositoAEAngela Esposito
- Carmela PutinoCPCarmela Putino
- Antonio MalvasiAMAntonio Malvasi
- Gianluca Raffaello DamianiGianluca Raffaello Damiani
- Antonio Simone LaganàAntonio Simone Laganà
- Amerigo VitaglianoAmerigo Vitagliano
- Marco MarinaccioMMMarco Marinaccio
- Leonardo RestaLeonardo Resta
- Ettore CicinelliECEttore Cicinelli
- Gerardo CazzatoGerardo Cazzato
Open Access
- 19 December 2022
- journal article
- case report
- Published by MDPI AG in Diagnostics
- Vol. 12 (12) , 3219
Abstract
Minimally invasive treatment of uterine fibroids usually requires a power morcellation, which could be associated with several complications. A rare sequela is disseminated peritoneal leiomyomatosis. Indeed, recurrence or metastasis in these cases could be attributed to iatrogenic or under-evaluation of primary tumors, although a subset of cases is a sporadic sample of biological progression. We present an extremely rare case of a patient who underwent laparoscopic morcellation and after 12 years developed a pelvic leiomyosarcoma with two omental metastases, disseminated peritoneal leiomyomatosis with a parasite leiomyoma with bizarre nuclei and a parasite cellular leiomyoma simultaneously. The diagnosis was predicted preoperatively by an expert sonographer who recognized the ultrasound characteristics of uterine sarcoma and the localization of some of the masses, so the patient was referred to the gynaecological oncologists who could appropriately treat her. We present here a case report and a systematic review that could be a useful tool for further discussion and future clinical practice guidelines.Keywords
This publication has 69 references indexed in Scilit:
- Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosisGynecologic Oncology, 2012
- Role of radiotherapy treatment of uterine sarcomaBest Practice & Research Clinical Obstetrics & Gynaecology, 2011
- A nomogram to predict postresection 5‐year overall survival for patients with uterine leiomyosarcomaCancer, 2011
- Adjuvant gemcitabine plus docetaxel for completely resected stages I–IV high grade uterine leiomyosarcoma: Results of a prospective studyGynecologic Oncology, 2009
- Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patientsHistopathology, 2009
- A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcomaCancer, 2008
- Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)European Journal of Cancer, 2008
- Secondary cytoreduction in the management of recurrent uterine leiomyosarcomaGynecologic Oncology, 2007
- Leiomyomatosis peritonealis disseminata with malignant change in a post-menopausal womanGynecologic Oncology, 2004
- Malignant Degeneration in Leiomyomatosis Peritonealis DisseminataGynecologic Oncology, 1996